Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window HOUSTON -- Use of transvenous phrenic nerve stimulation (TPNS) ...

Five-year data supported the long-term safety and effectiveness of transvenous phrenic nerve stimulation (TPNS) for central sleep apnea (CSA), investigators said. CSA severity decreased in patients ...

Please provide your email address to receive an email when new articles are posted on . Five-year data show sustained safety and efficacy outcomes after implantation of a transvenous phrenic nerve ...

ZOLL Announces Five-Year Study Confirming Safety, Efficacy and Beneficial Effects of Long-Term Transvenous Phrenic Nerve Stimulation (the remedē System) Study results published in the peer-reviewed ...

Researchers examined patients with central sleep apnea after 5 years of treatment with transvenous phrenic nerve stimulation therapy. This article is part of MPR’s coverage of the CHEST Virtual 2020 ...

A small implant being studied for the treatment of central sleep apnea is showing significant promise, according to researchers from the Ohio State University Wexner Medical Center. William Abraham, ...

New devices can help to manage sleep apneas, but underlying conditions must be treated, too, noted Krishna M. Sundar, MD, clinical professor, Pulmonary Division, Department of Medicine, medical ...

CHELMSFORD, Mass., September 09, 2025--(BUSINESS WIRE)--ZOLL ®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that transvenous phrenic nerve ...

EXTON, Pa.--(BUSINESS WIRE)--Lungpacer Medical, Inc. today announced results from the RESCUE 2 multicenter, randomized, controlled trial presented at the European Respiratory Society (ERS) 2020 ...